The dedication ceremony for the Avison Biomedical Research Center (ABMRC) was held on April 10 at the Yonsei University Health System (YUHS) Campus. In his speech, President and CEO of YUHS, Lee Chul, said: “It is very special that the Avison Biomedical Research Center is opening almost exactly 100 years after the Department of Education and Research was founded by Dr. Avison in 1914. The Avison Biomedical Research Center will accelerate the research-based medical industrialization policy that Severance Hospital is intent on implementing.” The ABMRC, which is now the largest biomedical research institution in Korea, also contains a sizeable animal laboratory and imaging center. The ABMRC is envisioned as an international biomedical research center, one that will become a leader in medical technology research, as well as Asia’s foremost center for animal experimentation. The ABMRC consists of a number of general and specialized laboratories, along with facilities for humanely and sanitarily housing animals. In particular, the experimental animal laboratory, which has a Bio Safety Level-3, contains 7,500 cages for smaller-sized animals, 284 cages for middle- to large-sized animals, 6 operating rooms, and an animal imaging center. Other facilities include an electrophysiological room, a tissue pathology room, an electron microscope room, and a radiation laboratory. The animal imagining room is equipped with state of the art technology, including MRI and micro-CT scanners and equipment for hyperpolarization and optical in vivo imaging. The ABMRC has also recruited world-renowned scholars. These include Professor Lee Sur-koo, who serves as Director of ABMRC, and Professor Back Sun-myeong. Professor Lee, who has published some 350 articles in scientific journals, established the phospholipase signal delivery system in the 1980s and 90s, and, in 1988, he discovered the antioxidant protein peroxiredoxin. Professor Back is a globally-recognized pathologist in the field of breast cancer research, who, in 2010, received the prestigious Komen Breen Kerr Award.